Literature DB >> 9354418

Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.

S E Dunn1, F W Kari, J French, J R Leininger, G Travlos, R Wilson, J C Barrett.   

Abstract

Diet contributes to over one-third of cancer deaths in the Western world, yet the factors in the diet that influence cancer are not elucidated. A reduction in caloric intake dramatically slows cancer progression in rodents, and this may be a major contribution to dietary effects on cancer. Insulin-like growth factor I (IGF-I) is lowered during dietary restriction (DR) in both humans and rats. Because IGF-I modulates cell proliferation, apoptosis, and tumorigenesis, the mechanisms behind the protective effects of DR may depend on the reduction of this multifaceted growth factor. To test this hypothesis, IGF-I was restored during DR to ascertain if lowering of IGF-I was central to slowing bladder cancer progression during DR. Heterozygous p53-deficient mice received a bladder carcinogen, p-cresidine, to induce preneoplasia. After confirmation of bladder urothelial preneoplasia, the mice were divided into three groups: (a) ad libitum; (b) 20% DR; and (c) 20% DR plus IGF-I (IGF-I/DR). Serum IGF-I was lowered 24% by DR but was completely restored in the IGF-I/DR-treated mice using recombinant IGF-I administered via osmotic minipumps. Although tumor progression was decreased by DR, restoration of IGF-I serum levels in DR-treated mice increased the stage of the cancers. Furthermore, IGF-I modulated tumor progression independent of changes in body weight. Rates of apoptosis in the preneoplastic lesions were 10 times higher in DR-treated mice compared to those in IGF/DR- and ad libitum-treated mice. Administration of IGF-I to DR-treated mice also stimulated cell proliferation 6-fold in hyperplastic foci. In conclusion, DR lowered IGF-I levels, thereby favoring apoptosis over cell proliferation and ultimately slowing tumor progression. This is the first mechanistic study demonstrating that IGF-I supplementation abrogates the protective effect of DR on neoplastic progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354418

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  123 in total

1.  The conundrum of height and mortality.

Authors:  George Davey Smith
Journal:  West J Med       Date:  2002-05

2.  Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk.

Authors:  G D Smith; D Gunnell; J Holly
Journal:  BMJ       Date:  2000-10-07

3.  Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake.

Authors:  R Michael Anson; Zhihong Guo; Rafael de Cabo; Titilola Iyun; Michelle Rios; Adrienne Hagepanos; Donald K Ingram; Mark A Lane; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

Review 4.  The somatotropic axis and longevity in mice.

Authors:  H M Brown-Borg
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-28       Impact factor: 4.310

5.  When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Authors:  Noriko N Yokoyama; Andria Denmon; Edward M Uchio; Mark Jordan; Dan Mercola; Xiaolin Zi
Journal:  Curr Pharmacol Rep       Date:  2015-04-14

Review 6.  Cancer.

Authors:  Adda Grimberg
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

Review 7.  Mechanisms by which IGF-I may promote cancer.

Authors:  Adda Grimberg
Journal:  Cancer Biol Ther       Date:  2003 Nov-Dec       Impact factor: 4.742

8.  Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults.

Authors:  David Berrigan; Nancy Potischman; Kevin W Dodd; Stephen D Hursting; Jackie Lavigne; J Carl Barrett; Rachel Ballard-Barbash
Journal:  Growth Horm IGF Res       Date:  2008-09-21       Impact factor: 2.372

9.  Distinct effects of calorie restriction and exercise on mammary gland gene expression in C57BL/6 mice.

Authors:  Michela Padovani; Jackie A Lavigne; Gadisetti V R Chandramouli; Susan N Perkins; J Carl Barrett; Stephen D Hursting; L Michelle Bennett; David Berrigan
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

10.  Insulin-like growth factor-I and cancer mortality in older men.

Authors:  Jacqueline M Major; Gail A Laughlin; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.